13F Holdings
中文EN

ILMN ILLUMINA, INC.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1110803 · Fiscal year ends 01/03

Financial factors as of 2026-09-27 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.8%
TTM net income YoY27.5%
TTM EPS YoY30.3%
Revenue 3-yr CAGR0.5%
Net income 3-yr CAGR—

Margins

Gross margin67.9%
Operating margin21.2%
Net margin19.7%
FCF margin23.3%
EBITDA margin27.1%

Returns

ROE32.4%
ROA13.8%
ROIC (approx.)51.0%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets53.8%
Debt / equity0.00x
Current ratio2.63x
Interest coverage9.80x

Cash quality & payout

Operating cash flow / net income1.37x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue3.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-28FY20242024-12-29FY20232023-12-31FY20222023-01-01FY20212022-01-02
Income statement
Revenue$4.34B$4.37B$4.50B$4.58B$4.53B
Cost of revenue$1.47B$1.51B$1.76B$1.61B$1.37B
Gross profit$2.87B$2.86B$2.74B$2.97B$3.15B
R&D expense$967.00M$1.17B$1.35B$1.32B$1.19B
SG&A expense$1.09B$1.09B$1.61B$1.30B$2.09B
Operating income$807.00M-$833.00M-$1.07B-$4.18B-$123.00M
Interest expense$101.00M$100.00M$77.00M$26.00M$61.00M
Pretax income$1.09B-$1.18B-$1.12B-$4.34B$884.00M
Income tax$236.00M$44.00M$44.00M$68.00M$122.00M
Net income$850.00M-$1.22B-$1.16B-$4.40B$762.00M
EBITDA$1.08B-$479.00M-$637.00M-$3.79B$128.00M
EPS (basic)5.47-7.69-7.34-28.005.07
EPS (diluted)5.45-7.69-7.34-28.005.04
Weighted avg. shares (diluted)156.00M159.00M158.00M157.00M151.00M
Balance sheet
Cash & equivalents$1.42B$1.13B$1.05B$2.01B$1.23B
Short-term investments$215.00M$93.00M$6.00M$26.00M$107.00M
Receivables$854.00M$735.00M$734.00M$671.00M$648.00M
Inventory$564.00M$547.00M$587.00M$568.00M$431.00M
Current assets$3.29B$2.75B$2.61B$3.56B$2.71B
PP&E, net$759.00M$815.00M$1.01B$1.09B$1.02B
Goodwill$1.11B$1.11B$2.54B$3.24B$7.11B
Intangibles$210.00M$295.00M$2.99B$3.29B$3.25B
Total assets$6.64B$6.30B$10.11B$12.25B$15.22B
Current liabilities$1.58B$1.55B$1.57B$2.77B$1.09B
Short-term debt————$0
Total liabilities$3.92B$3.93B$4.37B$5.65B$4.48B
Shareholders' equity$2.72B$2.37B$5.75B$6.60B$10.74B
Shares outstanding153.00M159.00M159.00M158.00M157.00M
Cash flow statement
Operating cash flow$1.08B$837.00M$478.00M$392.00M$545.00M
Capital expenditure$148.00M$128.00M$195.00M$286.00M$208.00M
Free cash flow$931.00M$709.00M$283.00M$106.00M$337.00M
Investing cash flow-$55.00M-$178.00M-$231.00M-$591.00M-$1.07B
Financing cash flow-$744.00M-$570.00M-$1.21B$1.00B-$51.00M
Depreciation & amortization$270.00M$354.00M$432.00M$394.00M$251.00M
Stock-based compensation$275.00M$370.00M$380.00M$366.00M$754.00M
Share buybacks$742.00M$116.00M$0$0$0

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.